In an effort to pay less for prescription drugs, the Federal agency that oversees Medicare is pursuing an ill-advised plan to cut Medicare reimbursement for cancer drugs. In the process, it could disrupt care for many thousands of cancer patients – especially those in small towns and rural communities.
Read Full Article »
